Several chemotherapy prodrugs have been developed and are in clinical use. A classic example is capecitabine, an oral prodrug of 5-fluorouracil, which is preferentially activated in tumor tissues. Another example is irinotecan, which is converted to its active metabolite SN-38 by carboxylesterase enzymes.
